Despite the discovery of the primary ferroptosis pathway involving GSH-GPX4, the precise regulatory network underlying the drug-tolerant state’s role in head and neck squamous cell carcinoma (HNSC) remains largely unclear. This evidence concerns the gene GPX4 and head and neck squamous cell carcinoma.